Wikisage, the free encyclopedia of the second generation, is digital heritage
Riociguat: Difference between revisions
Jump to navigation
Jump to search
(nl+) |
(→Links) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate. | Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate. Riociguat is a [[Soluble_guanylyl_cyclase|sCG ]] stimulator. | ||
contraindicated with nitrates. | contraindicated with nitrates. | ||
==ATC== | [[File:Riociguat-3D-balls.png|thumb]] | ||
==[[ATC]]== | |||
Antihypertensives for pulmonary arterial hypertension | |||
<ref>http://www.whocc.no/atc_ddd_index/?code=C02KX05</ref> | |||
==Links== | |||
*[http://www.sciencedirect.com/science/article/pii/S0012369216589570 Comparative Effectiveness of Pharmacological Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis] | |||
*[http://link.springer.com/article/10.1007%2Fs00101-016-0207-y Pulmonale Hypertonie Was ist neu in der Therapie?] | |||
{{refs}} | |||
[[nl:Riociguat]] | [[nl:Riociguat]] | ||
